Revance Therapeutics, Inc. $2,556,983 Glaukos Corp $3,912,133 Si-Bone, Inc. $0 Revance Therapeutics, Inc. $2,556,983 Glaukos Corp $3,912,133 Si-Bone, Inc. $0